FY23 Results - Investor Presentation
Asset Quality (Reported)
| Impairment charges significantly lower
Net Impairment (YoY Movement)
RM' mil
1.7
351.7
34.9
269.7
1,119.5
766.0
767.7
200.8
70.0
254.8
3.2
286.1
67.5
353.6
Overlay (PL) (RM'mil):
Q1FY23: 30.0
Q2FY23: 0.6
Q3FY23: (4.5)
Q4FY23: 41.4
113.2
466.9
FY22
Reported
AmGen FY22
impairment
FY22
Continuing
Overlay
write-back
FY22 before
overlay
ECL
Stage 1 & 2
ECL
Stage 3
Individual Recoveries Commitments Others
Allowance
&
Contingencies
FY23
before
overlay
Overlay
charge
FY23
Continuing
AmGen FY23
impairment
FY23
Reported
Positive P&L impact in FY23
Negative P&L impact in FY23
Gross Impaired Loans and LLC Ratios
Credit Cost and New Impaired Loans Formation
Retail
Business
114.0%
Wholesale
GIL Ratio 2
Loan Loss Coverage (incl RR) 1/2
1,2
AmBank Group
FY20
FY21
FY22
FY23
2
Loan Loss Coverage (excl RR)
124.1%
139.2%
127.7%
93.4%
Net credit cost³ (%)
(excl. overlay)
0.17%
0.44%²
0.39%2
0.27%
124.1%
133.1%
116.5%
Net credit cost³ (%)
0.30%
0.81%2
0.26%2
0.32%
86.2%
72.5%
1.59%
1.73%
1.57%
1.40%
1.46%
Credit cost4
RM' mil
1,853
1,896
(excl. recoveries) (%)
0.62%
1.12%2
0.46%2
0.56%
1,770
1,621
1,676
283
333
260
217
266
New Impaired Loans (RM'mil)
1,491
990
1,357
1,961
222
646
628
517
676
1.
1,342
924
2.
728
882
893
Includes regulatory reserve of RM388m (FY20), NIL (FY21), RM103m (FY22) and RM212m (FY23)
Restatement of numbers due to reclassified unrated bonds/sukuk from loans to financial
investments from Q1FY21 to Q4FY22 (Apr 20 to Mar'22)
3.
FY19
FY20
FY21
FY22
FY23
Computed based on net loan loss allowances (FS Note A25) of RM323m (FY20), RM913m (FY21),
RM314m (FY22), RM422m (FY23)
4.
Computed based on gross loan loss allowances (FS Note A25) of RM666mil (FY20), RM1,265mil
(FY21), RM555m (FY22), RM732 (FY23)
20
AmBank Group
FY23 Results - Investor PresentationView entire presentation